Elekta AB
(OTC: EKTAY)
|
4:46 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $6.50 | Change: +0.39 | %Change: +6.42% | Volume: 15,374 |
Open: | $ 6.29 | Volume: | 15,374 | |
---|---|---|---|---|
High: | $ 6.50 | Yield(%) | 2.49 | |
Low: | $ 6.20 | P/E Ratio (ttm): | 19.28 | |
Dividend ($): | 0.08 | Market Cap ($): | 2.27B | |
EPS ($) | 0.32 | Shares Out: | 367.10M |
% Price Change (last 4 weeks): | -23.91 |
---|---|
% Price Change (last 13 weeks): | -20.09 |
% Price Change (last 26 weeks): | -26.51 |
% Price Change (last 52 weeks): | -19.76 |
% Price Change (year to date): | -24.34 |
Return on Equity (%): | 12.68 |
---|---|
Return on Assets (%): | 4.22 |
Return on Invested Capital (%): | 8.04 |
Gross Profit Margin (%): | 37.40 |
---|---|
Net Profit Margin (%): | 7.19 |
Operating Profit Margin (%): | 13.04 |
|
|
50-day Moving Average: | $7.04 |
---|---|
200-day Moving Average: | $7.33 |
Avg. Daily Vol. (last 50 days): | 12,490 |
Avg. Daily Vol. (last 200 days): | 10,991 |
52-wk high: | $8.62 |
52-wk low: | $6.04 |
Bid: | $n/a |
Ask: | $n/a |
Elekta AB is a medical technology company, which engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: North and South America, Europe, Middle East and Africa and Asia Pacific. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.
|
Elekta AB
Kungstensgatan 18 Stockholm SD 103 93 Phone: 46.8.587.254.00 Fax: n/a http://www.elekta.com |
Earnings (1year) ($): | 0.32 |
---|---|
Annual Dividend ($): | n/a |
Current P/E Ratio (ttm): | 19.28 |
Book Value ($): | 2.57 |
Cash Flow ($): | n/a |
Price/Earnings (x): | 19.28 |
---|---|
Price/Sales (x): | 1.62 |
Price/Book (x): | 2.81 |
Price/Cash Flow (x): | 11.92 |
Quick Ratio (x): | 0.76 |
---|---|
Current Ratio (x): | 1.00 |
LT Debt/Equity (x): | 54.78 |
Total Debt/Equity (x): | 67.27 |